ClinConnect ClinConnect Logo
Search / Trial NCT04246970

Prehabilitation and Posttransplant Training Program in Liver Transplantation

Launched by MARIA DELS ANGELS CEBRIA I IRANZO, PT, PHD · Jan 27, 2020

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Prehabilitation Therapeutic Exercise Functional Capacity

ClinConnect Summary

The main objective is to study the post-surgical impact (post-S) of a Prehabilitation program on candidates for liver transplantation (LT), as well as to study the effects of posttransplant training on the clinical and functional evolution of the recipients. Also this project pretends to assess the influence of functional capacity (FC) improvement on the short and long term post-S evolution of the LT candidates. This is a prospective randomized clinical trial in which three phases follow: Prehabilitation, training and follow-up. The sample will be constituted by 60 candidates for LT, random...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Indication of elective liver transplant with favorable cardiorespiratory evaluation that does not contraindicate the transplant.
  • Exclusion Criteria:
  • Any orthopedic, motor, functional, neurological, cognitive or linguistic limitation that prevents the realization of the Prehabilitation program
  • Inability to perform psychometric tests
  • Esophageal varices not treated with ligature or beta-blockers
  • Varicose veins with a high risk of digestive hemorrhage
  • Hemoglobin \<80 g/l
  • Contraindication to weight loading
  • Impossibility to comply with the Prehabilitation program (hospital admission, work, geographical location)
  • Multi-organ transplantation and liver retransplantation
  • Refusal or lacks capacity to give informed consent

About Maria Dels Angels Cebria I Iranzo, Pt, Phd

Maria dels Angels Cebria i Iranzo, PT, PhD, is a distinguished clinical trial sponsor with extensive expertise in physical therapy and research methodologies. With a strong commitment to advancing healthcare through innovative clinical studies, Dr. Cebria i Iranzo leads rigorous trials focused on improving patient outcomes and enhancing therapeutic practices. Her academic background and practical experience allow her to effectively bridge the gap between clinical practice and research, ensuring that trials are designed and executed with the highest standards of scientific integrity and ethical considerations. Through her leadership, she aims to contribute significantly to the field of rehabilitation and therapeutic interventions.

Locations

Valencia, , Spain

Patients applied

0 patients applied

Trial Officials

Maria A Cebrià i Iranzo, PT, PhD

Principal Investigator

Hospital Universitari i Politècnic La Fe, Valencia

David Calatayud Mizrahi, MD, PhD

Study Chair

Hospital Universitari i Politècnic La Fe, Valencia

Natalia Cezón Serrano, PT

Study Chair

University of Valencia

Luis Compte Torrero, MD, PhD

Study Chair

Hospital Universitari i Politècnic La Fe, Valencia

Laura Arjona Tinaut, PT

Study Chair

University of Valencia

Rafael López Andújar, MD, PhD

Study Chair

Hospital Universitari i Politècnic La Fe, Valencia

Martín Prieto Castillo, MD, PhD

Study Chair

Hospital Universitari i Politècnic La Fe, Valencia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials